After six months of efforts, Pearl Ocean signed the Agreement of Maxipime Exclusive General Agent in China with Sino-American Shanghai Squibb Pharmaceuticals Ltd. (SASS) on April 1, 2011. This is the second major cooperation project after the successful Cefprozil Tablets agent project. OECD Department will lead the team of about 80 people to carry out the professional promotion activities. The introduction of "Maxipime" will create annual sales revenue of more than 100 million Yuan for the Group and lay a foundation for the cooperation between Pearl Ocean and foreign enterprises, as well as further enhance the Group’s reputation in the industry.